Skip to main content

JANE STREET GROUP, LLC

Position in TSHA — Taysha Gene Therapies, Inc.

CIK 1595888 NEW YORK, NY

Position in TSHA

as of Mar 31, 2026 · filed May 12, 2026
Position Value
$0
-$897,303 QoQ
Shares Held
0
-100.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Sep 2020
10 quarters on record

Common Shares in TSHA Over Time

Shares Held

Position Value (USD)

Derivatives in TSHA

reported options exposure · as of Mar 31, 2026
CallValue
$507,792
CallShares
113,600
PutValue
$60,345
PutShares
13,500

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Mar 31, 2026

JANE STREET GROUP, LLC holds $1,255,284,514 across 317 Biotechnology names.

# Ticker Company Shares Value (USD) Open

All Filings in TSHA

Export CSV
15 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $507,792 113,600
2026-03-31 $60,345 13,500
2025-12-31 $96,250 17,500
2025-12-31 $897,303 163,146
2025-12-31 $466,400 84,800
2025-09-30 $1,820,686 556,785
2025-09-30 $43,818 13,400
2025-06-30 $316,456 136,994
2025-06-30 $31,416 13,600
2024-12-31 $293,364 169,575
2024-09-30 $216,218 107,572
2024-06-30 $286,997 128,124
2024-03-31 $169,002 58,886
2023-12-31 $74,831 42,278
2020-09-30 $520,441 23,234